| Q41783600 | A coreceptor-independent transgenic human TCR mediates anti-tumor and anti-self immunity in mice. |
| Q37707149 | A quantitative increase in regulatory T cells controls development of vitiligo. |
| Q39225440 | Adaptive Immunity Is the Key to the Understanding of Autoimmune and Paraneoplastic Inflammatory Central Nervous System Disorders |
| Q41101471 | Concurrent OX40 and CD30 Ligand Blockade Abrogates the CD4-Driven Autoimmunity Associated with CTLA4 and PD1 Blockade while Preserving Excellent Anti-CD8 Tumor Immunity. |
| Q83436273 | Evaluation of NLRP1 gene polymorphisms in Vogt-Koyanagi-Harada disease |
| Q53726993 | Evaluation of the effect and mechanism of action of local phenytoin in treatment of vitiligo. |
| Q81441416 | Functional polymorphisms of the FAS gene associated with risk of vitiligo in Chinese populations: a case-control analysis |
| Q34692289 | GILT accelerates autoimmunity to the melanoma antigen tyrosinase-related protein 1. |
| Q50787510 | IL-33 circulating serum levels are increased in patients with non-segmental generalized vitiligo. |
| Q90540880 | Immune cells in the retina and choroid: Two different tissue environments that require different defenses and surveillance |
| Q37349741 | Immune privilege or privileged immunity? |
| Q51032468 | Increased serum levels of interleukin-23 circulating in patients with non-segmental generalized vitiligo. |
| Q47554064 | Inhibition of Human Immunodeficiency Type 1 Virus (HIV-1) Life Cycle by Different Egg White Lysozymes |
| Q38163168 | Innate immune mechanisms in vitiligo: danger from within |
| Q27014040 | Lymphopenia-induced proliferation in aire-deficient mice helps to explain their autoimmunity and differences from human patients |
| Q30433217 | Mechanisms of spatial and temporal development of autoimmune vitiligo in tyrosinase-specific TCR transgenic mice |
| Q91727091 | Mouse Model for Human Vitiligo |
| Q35008681 | Possible association of the CD4 gene polymorphism with vitiligo in an Iranian population. |
| Q47426230 | Role of chemokines and the corresponding receptors in vitiligo: A pilot study |
| Q37817215 | SEREX, Proteomex, AMIDA, and beyond: Serological screening technologies for target identification |
| Q39976037 | T-cell reconstitution after thymus xenotransplantation induces hair depigmentation and loss |
| Q33889471 | Th17 cells and activated dendritic cells are increased in vitiligo lesions |
| Q39419931 | Vitiligo: Focus on Clinical Aspects, Immunopathogenesis, and Therapy |
| Q83835934 | [Vitiligo. Diagnosis, differential diagnosis, and current patient management] |